[HTML][HTML] Reprogramming the tumor microenvironment by genome editing for precision cancer therapy

K Liu, JJ Cui, Y Zhan, QY Ouyang, QS Lu, DH Yang… - Molecular Cancer, 2022 - Springer
The tumor microenvironment (TME) is essential for immune escape by tumor cells. It plays
essential roles in tumor development and metastasis. The clinical outcomes of tumors are …

[HTML][HTML] Remdesivir and COVID-19

LY Wang, JJ Cui, QY Ouyang, Y Zhan, CX Guo, JY Yin - The Lancet, 2020 - thelancet.com
1 Wang Y, Zhang D, Du G, et al. Remdesivir in adults with severe COVID-19: a randomised,
double-blind, placebo-controlled, multicentre trial. Lancet 2020; 395: 1569–78. 2 Cao B, …

[HTML][HTML] Pharmacoepitranscriptomic landscape revealing m6A modification could be a drug-effect biomarker for cancer treatment

K Liu, QY Ouyang, Y Zhan, H Yin, BX Liu… - … Therapy-Nucleic Acids, 2022 - cell.com
RNA chemical modifications are a new but rapidly developing field. They can directly affect
RNA splicing, transport, stability, and translation. Consequently, they are involved in the …

[HTML][HTML] Complex analysis of the personalized pharmacotherapy in the management of COVID-19 patients and suggestions for applications of predictive, preventive …

LY Wang, JJ Cui, QY OuYang, Y Zhan, YM Wang… - EPMA Journal, 2021 - Springer
Aims Coronavirus disease 2019 (COVID-19) is rapidly spreading worldwide. Drug therapy
is one of the major treatments, but contradictory results of clinical trials have been reported …

The clinical characteristics and mortal causes analysis of COVID-19 death patients

AX Guo, JJ Cui, QY OuYang, L He, CX Guo, JY Yin - MedRxiv, 2020 - medrxiv.org
Purpose Currently, COVID-19 is causing a large number of deaths globally. However, few
researches focused on the clinical features of death patients. This study conducted a …

Genetic profiles in Pharmacogenes indicate personalized drug therapy for COVID-19

LY Wang, JJ Cui, QY OuYang, Y Zhan, YM Wang… - medRxiv, 2020 - medrxiv.org
Background The coronavirus disease 2019 (COVID-19) has become a global pandemic
currently. Many drugs showed potential for COVID-19 therapy. However, genetic factors which …

The clinical characteristics and mortal causes analysis of COVID-19 death patients (preprint)

AX Guo, JJ Cui, QY OuYang, L He, CX Guo, JY Yin - 2020 - pesquisa.bvsalud.org
Abstract Purpose: Currently, COVID-19 is causing a large number of deaths globally. However,
few researches focused on the clinical features of death patients. This study conducted a …

Genetic Profiles in Pharmacogenes Indicate Personalized Drug Therapy for COVID-19 (preprint)

LY Wang, JJ Cui, QY OuYang, Y Zhan, YM Wang… - 2020 - pesquisa.bvsalud.org
Background: The coronavirus disease 2019 (COVID-19) has become a global pandemic
currently. Many drugs showed potential for COVID-19 therapy. However, genetic factors which …

[HTML][HTML] circTADA2As suppress breast cancer progression and metastasis via targeting miR-203a-3p/SOCS3 axis

…, XJ Wang, X Zhao, JQ Chen, YX Ouyang… - Cell death & …, 2019 - nature.com
More and more evidence indicates that circular RNAs (circRNAs) have important roles in
several diseases, especially in cancers. However, their involvement remains to be investigated …

Enhancing the performance of Escherichia coli-inoculated microbial fuel cells by introduction of the phenazine-1-carboxylic acid pathway

…, Z Wang, X Wang, S Xu, K Chen, P Ouyang - Journal of …, 2018 - Elsevier
Microbial fuel cells (MFCs) are a renewable green energy source that uses microorganisms
to catalytically convert chemical energy into electrical energy. The efficiency of extracellular …